arrow
S

Stephan Eisenmann

martin luther university halle wittenberg
H指数:14
被引数:1,000

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognosis and aetiology of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) in patients with active lung or lower head and neck cancer (PEPP-C): a retrospective, matched multicentre cohort study in Germany and Spain

医院获得性肺炎(HAP)和呼吸机相关性肺炎(VAP)在活动性肺或头颈部癌症患者中的预后和病因(PEPP-C):一项在德国和西班牙进行的回顾性、匹配的多中心队列研究

2026-05-040
OAAI
Fatal disseminated Rhizomucor pusillus mucormycosis with pulmonary involvement diagnosed by contrast-enhanced ultrasound (CEUS) and transcutaneous biopsy in a patient with acute myeloid leukemia

急性髓系白血病患者中,经增强超声(CEUS)和经皮活检诊断的累及肺部并导致死亡的播散性根毛霉(Rhizomucor pusillus)毛霉菌病

2026-05-010
PRE
Peri-interventional antibiotic prophylaxis in endoscopic valve implantation for lung volume reduction in COPD patients: results from a German multicenter observational cohort

经干预抗生素预防在用于COPD患者肺减容的经内镜瓣膜植入术中的应用:德国多中心观察性队列研究的结果

2026-02-130
OAAI
Sex-Specific Phenotypes and Outcomes in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease: Results from the INSIGHTS-ILD Registry

性别特异性表型及结局在非特发性肺纤维化间质性肺疾病中的表现:INSIGHTS-ILD登记研究的结果

2026-02-010
OA
Efficacy and Safety of Lung Volume Reduction with Endobronchial Coil #2 and Coil #4 Results of the German Emphysema Registry-Lungenemphysemregister e.V.

经支气管镜线圈(Coil #2和Coil #4)肺减容术的疗效与安全性:德国肺气肿登记研究(Lungenemphysemregister e.V.)的结果

2025-12-311
OA
Limited Benefit of Additional Chartis® Assessments for Collateral Ventilation Evaluation in Patients with Software Quantified Intact Target Lobe Fissure – Results from a Retrospective Analysis of the German Lung Emphysema Registry

在软件量化完整目标肺叶裂隙的患者中,额外的Chartis<sup>&reg;</sup>评估对侧支通气评价的有限益处——德国肺气肿登记研究回顾性分析的结果

2025-12-040
OAAI
Late Breaking Abstract- Real-life characteristics and management of patients with fibrosing interstitial lung disease: INSIGHTS-ILD registry
2024-10-300
PRE
Lung volume reduction with one-way valves in patients with a very low FEV1: Assessment of efficacy and safety up to 6 months with results from the German Lung emphysema registry (LE-R)
2023-10-270
PRE
Assessment of clinical outcome after endoscopic lung volume reduction with oneway valves in emphysema patients and a verylow 6 minute walk test at baseline
2023-10-270
PRE
Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis

肺动脉高压和合并症患者的危险分层和对治疗的反应: COMPERA分析

2023-01-0142
OAAI
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis

特发性肺动脉高压的表型: 注册分析

2022-10-0187
OAAI
Endoscopic Lung Volume Reduction with One-Way Valves in Patients with Severe Chronic Obstructive Pulmonary Disease with Hypercapnia
2022-07-047
PRE
Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis
2022-07-0115
OAAI